Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-02, Stock:NVS, The news for the past five days is as follows:
2021-10-26: NEWS1: Novartis Mulls Selling Underperforming Unit As Sales Decline Continues.NEWS2: Novartis (NVS) Q3 2021 Earnings Call Transcript.NEWS3: Novartis (NVS) Q3 Earnings Beat, Sandoz Under Strategic Review.NEWS4: Novartis Boosts Guidance For These Key Drugs After Their Bang-Up Quarter.NEWS5: The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children.NEWS6: Novartis Starts Review of Generic-Drug Unit.NEWS7: Novartis mulls spinning off Sandoz generic drug unit.NEWS8: Novartis May Spin Off or Sell Ailing Sandoz Generics Unit.NEWS9: Novartis may divest generic unit Sandoz as price pressures mount.NEWS10: Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz.
2021-10-27: NEWS1: Company News for Oct 27, 2021.
2021-10-28: NEWS1: Will Higher Jakafi Sales Boost Incyte's (INCY) Q3 Earnings?.
2021-10-29: NEWS1: FDA approves Novartis Scemblix® (asciminib), with novel mechanism of action for the treatment of chronic myeloid leukemia.NEWS2: Pharma Stock Roundup: Big Pharma Q3 Results, FDA Panel's Vote for PFE COVID Jab.NEWS3: The Zacks Analyst Blog Highlights: Berkshire Hathaway, Visa, Novartis, Advanced Micro Devices and Deere.
2021-11-01: nan

Answer: Decrease